Targeting CXCL13 During Neuroinflammation

Advances in Neuroimmune Biology - Netherlands
doi 10.3233/nib-150101
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IOS Press

Related search

CXCL13 and Neopterin Concentrations in Cerebrospinal Fluid of Patients With Lyme Neuroborreliosis and Other Diseases That Cause Neuroinflammation

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2014English

Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases

CNS and Neurological Disorders - Drug Targets
MedicineNeurosciencePharmacology
2011English

MicroRNA‑186‑5p Mediates Osteoblastic Differentiation and Cell Viability by Targeting CXCL13 in Non‑traumatic Osteonecrosis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Targeting Mitochondrial Metabolism in Neuroinflammation: Towards a Therapy for Progressive Multiple Sclerosis

Trends in Molecular Medicine
Molecular MedicineMolecular Biology
2018English

Early BAFF Receptor Blockade Mitigates Murine Sjögren's Syndrome: Concomitant Targeting of CXCL13 and the BAFF Receptor Prevents Salivary Hypofunction

Clinical Immunology
AllergyImmunology
2016English

Neuroinflammation

Neuroscience Bulletin
MedicineNeurosciencePhysiology
2015English

MFG-E8 Mediates Primary Phagocytosis of Viable Neurons During Neuroinflammation

Journal of Neuroscience
Neuroscience
2012English

Effect of Atorvastatin on Behavioral Alterations and Neuroinflammation During Epileptogenesis

Epilepsy and Behavior
NeurologyBehavioral Neuroscience
2018English

Single-Cell Profiling Reveals GPCR Heterogeneity and Functional Patterning During Neuroinflammation

JCI insight
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy